GRETCHEN RYLE: Open Payments
NPI 1972048593 · GLEN BURNIE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$62 in 3 payments from 3 companies in 2025. Trend: 2023 $99 · 2024 $71 · 2025 $62
Food & beverage: $62
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 1 | $30 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
Products named: ABILIFY MAINTENA, COBENFY, AUSTEDO XR.
Industry payments across MD — which companies pay providers there.
